AUS
NZ
UK
CA
USA
IND
Healthcare
Lumos partners with MedPro to broaden the US distribution of its FebriDx point-of-care respiratory test.
January 14, 2025 11:00 AM AEDT| By Team Kalkine MediaLumos partners with MedPro to broaden the US distribution of its FebriDx point-of-care respiratory test.
Telix Pharmaceuticals Expands Portfolio with $372M ImaginAb Deal
January 13, 2025 01:20 PM AEDT| By Team Kalkine MediaHighlights,Major Acquisition:,Telix Pharmaceuticals is acquiring early-stage drug candidates and a proprietary biologics platform from ImaginAb, Inc. for an initial $73 million, with an additional $299 million tied to future milestones.,Next-Generati...
4D Medical's Radioisotope-Free CT:VQ Technology Set for U.S. Department of Defense Pilot
January 13, 2025 01:16 PM AEDT| By Team Kalkine MediaHighlights:,U.S. DoD Pilot Program:,4D Medical has secured a pilot program with the U.S. Department of Defense to use its CT:VQ lung scanning technology, a major step toward formal FDA approval.,$1 Billion Market Opportunity:,The company aims to repl...
Telix Pharmaceuticals (ASX:TLX) Expands Oncology Pipeline with $372M Asset Acquisition
January 13, 2025 11:13 AM AEDT| By Team Kalkine MediaHighlights:,Telix,Pharmaceuticals Ltd (,ASX:TLX,) secures next-generation cancer drug candidates through a $372 million acquisition agreement with,ImaginAb,, Inc.,The deal includes early-stage assets targeting high-grade neuroendocrine,tumors,, small...
What Do Recent Insider Moves at SomnoMed Reveal?
January 13, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Chairman Gaetano Russo makes a significant stock purchase in SomnoMed.,Insiders collectively own around 7% of the company.,Insider activity over the last year has been focused on acquisitions, with no sales reported,Insider transactions c...
AnteoTech's silicon-dominant anodes are creating a significant impact in the battery industry.
January 12, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,AnteoTech advances lithium-ion batteries with silicon anodes, enhancing energy storage and reducing costs.,Collaborations with major companies demonstrate the commercial appeal of this innovative technology.,The focus remains on improving...
Is the Biotech Sector on the Brink of a New Era of Growth?
January 11, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,A resurgence in global biotech M&A activity signals renewed interest and growth within the sector, with key acquisitions by companies such as Johnson & Johnson, Eli Lilly, and GlaxoSmithKline.,Dimerix (ASX:DXB) reports significant progres...
Imugene (ASX:IMU) Receives $11.7M R&D Tax Refund to Boost Immunotherapy Developments
January 10, 2025 02:52 PM AEDT| By Team Kalkine MediaHighlights,Imugene (IMU) receives $11.7M tax refund for R&D projects.,The refund is part of Australia's R&D tax incentive scheme.,The refund amount includes both principal and interest.,Imugene (ASX:IMU), an Australian-based immunotherapy company, ha...
ResMed (ASX:RMD): A Strong Contender in the Growing Healthcare Sector
January 10, 2025 01:46 PM AEDT| By Team Kalkine MediaHighlights,ResMed's (RMD) share price has increased by 49% since the start of 2025.,The company has a robust presence in the global healthcare industry, focusing on sleep apnea treatment and software solutions.,Healthcare companies like ResMed are at...
Mesoblast Trading Halt Sparks Market Attention
January 10, 2025 12:31 PM AEDT| By Team Kalkine MediaHighlights,Mesoblast (MSB) enters a trading halt ahead of key announcement.,Trading,expected,to resume on January 14 or sooner if the announcement is made earlier.,Shares experienced a 4% dip during early Friday trading.,Australian biotech company Me...
Lantheus Acquires 12.16% Stake in Radiopharm Theranostics Through $8 Million Placement
January 10, 2025 11:16 AM AEDT| By Team Kalkine MediaHighlights,Lantheus,, a leading radiopharmaceutical company,,acquired,a 12.16% stake in,Radiopharm,Theranostics,(,ASX:RAD,) through an $8 million placement.,The placement price of 6 cents per share,represents,a 150% premium to,Radiopharm's,last closi...
Which healthcare stock experienced a significant drop this week following an earnings downgrade?
January 10, 2025 11:00 AM AEDT| By Team Kalkine MediaWhich healthcare stock experienced a significant drop this week following an earnings downgrade?
Avita Medical (ASX:AVH) Reports Slower-Than-Expected Q4, Falling Short of Revenue Targets
January 08, 2025 11:51 AM AEDT| By Team Kalkine MediaHighlights:,Avita Medical's (AVH) Q4 revenue increases by,30%, but,falls below expectations.,The company lowers its full-year revenue projection for 2024.,Strong expectations for 2025 with a projected revenue growth of up to 60%.,Avita Medical (ASX:A...
Island Pharmaceuticals Advances ISLA-101 to Phase 2b Trial for Dengue Fever Treatment
January 08, 2025 11:40 AM AEDT| By Team Kalkine MediaHighlights:,Successful Subject Enrolment:,Island Pharmaceuticals Ltd (,ASX:ILA,) has,commenced,its Phase 2b clinical trial for ISLA-101, enrolling the first subjects to assess the drug's therapeutic potential against dengue fever.,Focus on Treatment...
Orthocell’s Revenue Surge: A Sustained Growth Story
January 08, 2025 11:27 AM AEDT| By Team Kalkine MediaHighlights:,Record Revenue Growth:,Orthocell,Ltd (,ASX:OCC,) reported A$2.21 million in revenue for Q4 FY2024, marking its third consecutive quarter of record-breaking results, with a 9% increase from the previous quarter.,Global Market Expansion:,Pr...
4DMedical Soars After FDA Approval for AI Diagnostic Tool
January 07, 2025 02:42 PM AEDT| By Team Kalkine MediaHighlights,4DMedical (4DX) receives FDA clearance for its IQ-UIP product.,The innovative technology improves diagnosis for Interstitial Pulmonary Fibrosis.,Shares rise 12.7% following the announcement.,Shares in 4DMedical (ASX:4DX), a leading respira...
Argent BioPharma Secures $4.5M to Advance Neuro-Immune and Nano-Medicine Drug Pipeline, Shares Jump 47%
January 07, 2025 12:15 PM AEDT| By Team Kalkine MediaHighlights,Capital Raise Completion:,Argent BioPharma successfully raises US$4.5 million through the issue of 11.25 million shares and warrants.,Strategic Focus:,Funds will advance the CannEpil® clinical studies and support the company’s transition t...
Dimerix Partners with FUSO to Advance Kidney Disease Treatment in Japan
January 07, 2025 12:02 PM AEDT| By Team Kalkine MediaHighlights,Strategic Partnership:,Dimerix has signed an exclusive agreement with Japan’s FUSO Pharmaceutical Industries Ltd for the development and commercialization of DMX-200 in Japan.,Major Financial Boost:,The deal includes up to ¥10.5 billion (A...
Dimerix Partners with FUSO for Kidney Disease Drug Development in Japan
January 07, 2025 11:06 AM AEDT| By Team Kalkine MediaHighlights,Strategic Partnership:,Dimerix,Ltd (,ASX:DXB,) collaborates with FUSO Pharmaceutical Industries to develop and commercialise DMX-200 for FSGS kidney disease in Japan.,Exclusive Rights:,FUSO secures exclusive development, registration, and...
Star Combo Pharma (ASX:S66): Examining the 30% Price Surge Amid Revenue Concerns
January 06, 2025 06:56 PM AEDT| By Team Kalkine MediaHighlights,Star Combo Pharma Limited's (S66) share price surged by 30% this month.,Medium-term revenue trends show a decline despite recent gains.,Price-to-sales ratio aligns with industry but raises questions about sustainability.,The share price of...
Advertise your brand on Kalkine Media